GFAP and Alzheimer disease: Plasma glial fibrillary acidic protein (GFAP), which is a marker of neuroinflammation and reflects astrocytosis, is also associated with amyloid deposition in healthy controls, and SCI, MCI, and AD dementia patients.14, 15, 16, 17